相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Serum peptidome profiling in patients with gastric cancer
Juan Yang et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2012)
Identification of Novel Low Molecular Weight Serum Peptidome Biomarkers for Non-Small Cell Lung Cancer (NSCLC)
Juan Yang et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2012)
EVALUATION OF DUAL-SPECTRUM IR SPECTROGRAM SYSTEM ON INVASIVE DUCTAL CARCINOMA (IDC) BREAST CANCER
Chia-Yen Lee et al.
BIOMEDICAL ENGINEERING-APPLICATIONS BASIS COMMUNICATIONS (2011)
Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study
Annemieke W. J. Opstal-van Winden et al.
BMC CANCER (2011)
Serum Peptidome Profiling in Patients with Lung Cancer
Juan Yang et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2010)
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: Sources of sample bias
Dale McLerran et al.
CLINICAL CHEMISTRY (2008)
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer
Dale McLerran et al.
CLINICAL CHEMISTRY (2008)
Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer
Claudio Belluco et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Biomarkers for early detection of breast cancer: What, when, and where?
Victor V. Levenson
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2007)
Opinion - Shaping the future of biomarker research in breast cancer to ensure clinical relevance
M. Carolina Hinestrosa et al.
NATURE REVIEWS CANCER (2007)
ProteinChip array profiling for identification of disease- and chemotherapy-associated biomarkers of nasopharyngeal carcinoma
William C. S. Cho et al.
CLINICAL CHEMISTRY (2007)
The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome
Glen L. Hortin
CLINICAL CHEMISTRY (2006)
Serum biomarkers for detection of breast cancers: a prospective study
C Mathelin et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry
JN Li et al.
CLINICAL CHEMISTRY (2005)
SELDI-TOF-MS: the proteomics and bioinformatics approaches in the diagnosis of breast cancer
Y Hu et al.
BREAST (2005)
Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases
V Paradis et al.
HEPATOLOGY (2005)
Mass Spectrometry as a diagnostic and a cancer biomarker discovery tool - Opportunities and potential limitations
EP Diamandis
MOLECULAR & CELLULAR PROTEOMICS (2004)
Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry
J Villanueva et al.
ANALYTICAL CHEMISTRY (2004)
Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer
WA Berg et al.
RADIOLOGY (2004)
An overview of the status of imaging screening technology for breast cancer
JA Smith et al.
ANNALS OF ONCOLOGY (2004)
The use of proteomics for the assessment of clinical samples in research
S Aldred et al.
CLINICAL BIOCHEMISTRY (2004)
Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: Potential use in diagnosis and prognosis
KR Kozak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: An analysis of 27,825 patient evaluations
TM Kolb et al.
RADIOLOGY (2002)